Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Malignancies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Site, La Jolla, California, United States

  • Research Site, Los Angeles, California, United States

  • Research Site, San Francisco, California, United States

  • Research Site, Chicago, Illinois, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, Portland, Oregon, United States

  • Research Site, Houston, Texas, United States

  • Research Site, San Antonio, Texas, United States

  • Research Site, Richmond, Virginia, United States

  • Research Site, Darlinghurst, Australia

  • Research Site, Melbourne, Australia

  • Research Site, Randwick, Australia

  • Research Site, Bayern, Germany

  • Research Site, Berlin, Germany

  • Research Site, Heidelberg, Germany

  • Research Site, Mainz, Germany

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, A Coruña, Spain

  • Research Site, Barcelona, Spain

  • Research Site, Málaga, Spain

  • Research Site, Pozuelo de Alarcón, Spain

  • Research Site, Sant Cugat del Vallès, Spain

  • Research Site, Seville, Spain

  • Research Site, Lund, Sweden

  • Research Site, Stockholm, Sweden

  • Research Site, Glasgow, Scotland, United Kingdom

  • Research Site, London, United Kingdom

  • Research Site, Newcastle upon Tyne, United Kingdom